Michael W. Hoskins
Award-winning journalist, editorial leader, and content strategist with 25 years of experience spanning community news reporting, legal journalism, healthcare writing, medical content editing, and patient advocacy leadership.
● Open for Full-Time, Freelance, Contract, & Consulting Roles
Healthcare Journalism
Editorial Leadership
Medical Storytelling
Legal & Community News
Patient Advocacy
Selected health journalism, medical reviews, and editorial work published across Healthline Media (2022–2026).
Highlights & Impact
Editorial Volume & AI Workflow: "I help newsrooms and digital publications scale content responsibly and safely." Managed production of 12–36 monthly health articles while integrating generative AI into workflows to boost content velocity without sacrificing strict editorial and medical accuracy.
Audience Engagement & Revenue Growth: "I connect with people and turn traffic into revenue." Increased known-user acquisition by 25% and boosted health topic revenue by 33% using targeted content marketing and newsletters.
Team Leadership: "I guide publishing operations like a Great Lakes captain, supporting morale and growth through tight team alignment." Wrangled cross-functional teams of writers, copy editors, medical reviewers, and designers to keep complex digital publishing operations running smoothly, helping drive a 28% jump in site sessions.
Platform Launch: "I bring major digital products to life." Served on a 9-month tiger team to launch OptumNow, a first-of-its-kind B2C health marketplace that required editorial content strategy and cross-departmental coordination for the product launch.
Managing Editor for a digital consumer health site focused on the diabetes community (2012–2022).
Investigative Enterprise Journalism
- Four-part series on FDA Diabetes Device Recalls
News Coverage
- Newsflash: Diabetes Hands Foundation Merges with Beyond Type 1
- Tidepool Loop: The App for Automating Insulin Delivery
- Thousands Tune In for American Diabetes Association Virtual Scientific Sessions
- FDA OKs First Needle-Free Nasal Glucagon (Baqsimi) for Severe Hypoglycemia
- Newsflash: Animas Exiting Insulin Pump Market
- Newsflash: Roche Stops Selling Accu-Chek Insulin Pumps in US
Business Reviews and Profiles
High-Profile Interviews
Patient Advocacy Journalism
Enterprise Journalism Package
An in-depth investigation into systemic flaws and human costs of wrongful convictions. This 7-part series examined the causes of errors across various legal phases, highlighting post-conviction legal battles, reform initiatives, and the lasting personal impact on exonerees.
-30-

